Skip to content

Clinical trials

Phase 3 Bronchiectasis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiectasis Phase: Phase 3 Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20091
20112
20121
20131
20142
20181
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Gilead Sciences2
Syntara2
Aradigm Corporation1
Boehringer Ingelheim1
Mannkind Corporation1
Neovii Biotech1
The Alfred1
The University of Queensland1
Zambon SpA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiectasis13
Cystic Fibrosis2
Actinomycetales Infections1
Bacterial Infections1
Bacterial Infections and Mycoses1
Gram-Positive Bacterial Infections1
Idiopathic Pulmonary Fibrosis1
Infections1
Lung Diseases1
Mycobacterium Infections1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.